Dr. Bahal presented his exciting work at the Harvard Medical School Initiative for RNA Medicine Seminar series on June 23.

Dr. Bahal presented his exciting work on ”Next-generation microRNA targeting at the interface of nucleic acid chemistry and nanotechnology”, highlighting the role of non-coding RNAs for the treatment and diagnosis of cancer & other diseases. The goal of the Harvard Medical School Initiative for RNA Medicine is to make and translate RNA discoveries into novel therapeutics and diagnostics by fostering a climate of outstanding basic, translational and clinical research with world-leading scientists and clinicians.


This entry was posted in News.